Table 2.
Expanded Prostate Cancer Index Composite (EPIC) Scores Over Time in Our Patient Population (and Standard Deviations in Parentheses)
Baseline | 6 mo | 1 y | 2 y | Last Follow-Up | P | |
---|---|---|---|---|---|---|
Urinary summary | 91.6 (8.5) | 88.9 (11.6) | 87.3 (12.4) | 88.5 (11.6) | 88.6 (11.5) | <.001 |
Urinary function | 97 (6.9) | 94.5 (9.5) | 93.4 (10.3) | 94.2 (9.5) | 94 (9.9) | .0006 |
Urinary bother | 87.7 (11.9) | 84.9 (14.7) | 82.9 (15.8) | 84.4 (15.0) | 84.7 (14.7) | .0002 |
Urinary incontinence | 95.8 (9.2) | 93.8 (11) | 92.5 (13.2) | 92.2 (13.0) | 92 (12.9) | .0418 |
Urinary irritative/obstructive | 90.2 (9.6) | 87 (13.6) | 85.6 (14.7) | 87.5 (12.7) | 87.8 (12.7) | .0002 |
Bowel summary | 95.1 (5.8) | 91.7 (10.4) | 89.0 (11.7) | 90.3 (10.8) | 90.8 (10.3) | <.0001 |
Bowel function | 96 (6.9) | 91.9 (12.5) | 88.9 (14.6) | 90.8 (9.3) | 90.9 (12.5) | <.0001 |
Bowel bother | 94.1 (6.4) | 91.7 (9.5) | 89.3 (10.3) | 89.7 (13.7) | 91 (9.4) | <.0001 |
Sexual summary | 75.5 (17.8) | 67.7 (20) | 64.4 (22.0) | 62.9 (22.6) | 62.7 (22.1) | <.0001 |
Sexual function | 71.9 (17.1) | 64.2 (18.3) | 61.7 (20.7) | 60.6 (20.5) | 59.7 (20.5) | <.0001 |
Sexual bother | 84.3 (22.1) | 75.2 (26.9) | 71.0 (27.8) | 69.1 (30.2) | 70 (28.4) | <.0001 |
Hormone summary | 92.6 (9.2) | 90.7 (10.2) | 91.7 (9.7) | 91.8 (9.2) | 91.1 (9.7) | .7673 |
Hormone function | 89.9 (11.3) | 88.2 (12) | 89.2 (11.3) | 89.8 (10.9) | 88.9 (11.5) | .9567 |
Hormone bother | 94.5 (8.8) | 92.9 (9.9) | 93.8 (9.3) | 93.6 (8.6) | 93 (9.3) | .8169 |
Number of potential patients | 262 | 262 | 261 | 195 | 262 | – |
Number of patients with data | 255 | 243 | 237 | 170 | 262 | – |
Percent of patients with data | 97% | 93% | 91% | 87% | 100% | – |